Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 304, Issue 9, 2013, Pages

  Chow, Edwin C Y ^a   Quach, Holly P ^a   Vieth, Reinhold ^a   Sandy Pang, K ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

1 ,25 dihydroxyvitamin D3; 1 hydroxylase; 24 hydroxylase cytochrome P 450; 25 hydroxyvitamin D3; Cyp24a1; Cyp27b1; Member 6; Receptor; Subfamily V; Transient receptor potential cation channel; TRPV6; Vitamin

Indexed keywords

CALCITRIOL; CALCIUM; CYTOCHROME P450; CYTOCHROME P450 24A1; CYTOCHROME P450 27B1; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PARATHYROID HORMONE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 6; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE LEVEL; CALCIUM BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; ILEUM; KIDNEY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TISSUE LEVEL; VITAMIN BLOOD LEVEL;

1Α,25-DIHYDROXYVITAMIN D3; 1Α-HYDROXYLASE; 24-HYDROXYLASE CYTOCHROME P-450; 25-HYDROXYVITAMIN D3; CYP24A1; CYP27B1; MEMBER 6; SUBFAMILY V; TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL; TRPV6; VITAMIN D RECEPTOR;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; BLOTTING, WESTERN; CALCITRIOL; CALCIUM; CALCIUM CHANNELS; FEEDBACK, PHYSIOLOGICAL; INTESTINES; KIDNEY; MALE; MICE; MICE, INBRED C57BL; PARATHYROID HORMONE; PHOSPHORUS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CALCITRIOL; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEROID HYDROXYLASES; TRPV CATION CHANNELS; VITAMINS;

EID: 84878596734     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00489.2012     Document Type: Article

References (57)

1. Ahmed S, Johnson CS, Rueger RM, Trump DL. Calcitriol (1,25-dihydroxycholecalciferol) potentiates activity of mitoxantrone/dexamethasone in an androgen independent prostate cancer model. J Urol 168: 756-761, 2002.
2. Albert DM, Scheef EA, Wang S, Mehraein F, Darjatmoko SR, Sorenson CM, Sheibani N. Calcitriol is a potent inhibitor of retinal neovascularization. Invest Ophthalmol Vis Sci 48: 2327-2334, 2007.
3. Armbrecht HJ, Boltz MA. Expression of 25-hydroxyvitamin D 24-hydroxylase cytochrome P450 in kidney and intestine. Effect of 1,25-dihydroxyvitamin D and age. FEBS Lett 292: 17-20, 1991.
4. Bettoun DJ, Burris TP, Houck KA, Buck DW, 2nd Stayrook KR, Khalifa B, Lu J, Chin WW, Nagpal S. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Mol Endocrinol 17: 2320-2328, 2003.
5. Bianco SD, Peng JB, Takanaga H, Suzuki Y, Crescenzi A, Kos CH, Zhuang L, Freeman MR, Gouveia CH, Wu J, Luo H, Mauro T, Brown EM, Hediger MA. Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J Bone Miner Res 22: 274-285, 2007.
6. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
7. Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 14, Suppl 1: S55-S61, 2003.
8. Brandi L, Egfjord M, Olgaard K. Pharmacokinetics of 1,25(OH)2D3 and 1α(OH)D3 in normal and uraemic men. Nephrol Dial Transplant 17: 829-842, 2002.
9. Chen KS, DeLuca HF. Cloning of the human 1α,25-dihydroxyvitamin D3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim Biophys Acta 1263: 1-9, 1995.
10. Chen X, Chen F, Liu S, Glaeser H, Dawson PA, Hofmann AF, Kim RB, Shneider BL, Pang KS. Transactivation of rat apical sodiumdependent bile acid transporter and increased bile acid transport by 1α,25-dihydroxyvitamin D3 via the vitamin D receptor. Mol Pharmacol 69: 1913-1923, 2006.
11. Chow EC, Durk MR, Cummins CL, Pang KS. 1α,25-Dihydroxyvitamin D3 up-regulates P-glycoprotein via the vitamin D receptor and not farne-soid X receptor in both fxr(-/-) and fxr(++) mice and increased renal and brain efflux of digoxin in mice in vivo. J Pharmacol Exp Ther 337: 846-859, 2011.
12. Chow EC, Maeng HJ, Liu S, Khan AA, Groothuis GM, Pang KS. 1α,25-Dihydroxyvitamin D3 triggered vitamin D receptor and farnesoid X receptor-like effects in rat intestine and liver in vivo. Biopharm Drug Dispos 30: 457-475, 2009.
13. Chow EC, Sondervan M, Jin C, Groothuis GM, Pang KS. Comparative effects of doxercalciferol (1α-hydroxyvitamin D2) versus calcitriol (1α,25-dihydroxyvitamin D3) on the expression of transporters and enzymes in the rat in vivo. J Pharm Sci 100: 1594-1604, 2011.
14. Chow EC, Sun H, Khan AA, Groothuis GM, Pang KS. Effects of 1α,25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney in vivo. Biopharm Drug Dispos 31: 91-108, 2010.
15. Cui M, Li Q, Johnson R, Fleet JC. Villin promoter-mediated transgenic expression of transient receptor potential cation channel, subfamily V, member 6 (TRPV6) increases intestinal calcium absorption in wild-type and vitamin D receptor knockout mice. J Bone Miner Res 27: 2097-2107, 2012.
16. Cui M, Li Q, Johnson R, Fleet JC. Villin promoter-mediated transgenic expression of TRPV6 increases intestinal calcium absorption in wild-type and VDR knockout mice. J Bone Miner Res May 15. doi: 10.1002/ jbmr.1662, 2012.
17. Drocourt L, Ourlin JC, Pascussi JM, Maurel P, Vilarem MJ. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 277: 25125-25132, 2002.
18. Durk MR, Chan GN, Campos C, Peart J, Chow EC, Lee E, Cannon RE, Bendayan R, Miller DS, Pang KS. 1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells. J Neurochem 123: 944-953, 2012.
19. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 289: F8-F28, 2005.
20. Echchgadda I, Song CS, Roy AK, Chatterjee B. Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol Pharmacol 65: 720-729, 2004.
21. Eloranta JJ, Hiller C, Juttner M, Kullak-Ublick GA. The SLCO1A2 gene, encoding human organic anion-transporting polypeptide 1A2, Is transactivated by the vitamin D receptor. Mol Pharmacol 82: 37-46, 2012.
22. Fan J, Liu S, Du Y, Morrison J, Shipman R, Pang KS. Up-regulation of transporters and enzymes by the vitamin D receptor ligands, 1α,25-dihydroxyvitamin D3 and vitamin D analogs, in the Caco-2 cell monolayer. J Pharmacol Exp Ther 330: 389-402, 2009.
23. Feldman D, Pike JW, Glorieux FH. Vitamin D. Amsterdam, Boston: Elsevier Academic, 2005, p. 2 v. (XXIX, 1892 p.).
24. Ferraris RP, Villenas SA, Diamond J. Regulation of brush-border enzyme activities and enterocyte migration rates in mouse small intestine. Am J Physiol Gastrointest Liver Physiol 262: G1047-G1059, 1992.
25. Hedlund TE, Moffatt KA, Miller GJ. Vitamin D receptor expression is required for growth modulation by 1α,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31. J Steroid Biochem Mol Biol 58: 277-288, 1996.
26. Henry HL. The 25(OH)D3/1α,25(OH)2D3-24R-hydroxylase: a catabolic or biosynthetic enzyme? Steroids 66: 391-398, 2001.
27. Hershberger PA, Yu WD, Modzelewski RA, Rueger RM, Johnson CS, Trump DL. Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxelinduced apoptosis. Clin Cancer Res 7: 1043-1051, 2001.
28. Hoenderop JG, Nilius B, Bindels RJ. Calcium absorption across epithelia. Physiol Rev 85: 373-422, 2005.
29. Itoh S, Yoshimura T, Iemura O, Yamada E, Tsujikawa K, Kohama Y, Mimura T. Molecular cloning of 25-hydroxyvitamin D3 24-hydroxylase (Cyp-24) from mouse kidney: its inducibility by vitamin D3. Biochim Biophys Acta 1264: 26-28, 1995.
30. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev 78: 1193-1231, 1998.
31. Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, Kathpalia PP, DeLuca HF, Bushinsky DA, Favus MJ. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 20: 447-454, 2005.
32. Lemon BD, Freedman LP. Selective effects of ligands on vitamin D3 receptor-and retinoid X receptor-mediated gene activation in vivo. Mol Cell Biol 16: 1006-1016, 1996.
33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
34. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: the second decade. Cell 83: 835-839, 1995.
35. Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, Jones G. Altered pharmacokinetics of 1α,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology 146: 825-834, 2005.
36. Meyer MB, Zella LA, Nerenz RD, Pike JW. Characterizing early events associated with the activation of target genes by 1,25-dihydroxyvitamin D3 in mouse kidney and intestine in vivo. J Biol Chem 282: 22344-22352, 2007.
37. Muindi JR, Modzelewski RA, Peng Y, Trump DL, Johnson CS. Pharmacokinetics of 1α,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor doses. Oncology 66: 62-66, 2004.
38. Muindi JR, Peng Y, Potter DM, Hershberger PA, Tauch JS, Capozzoli MJ, Egorin MJ, Johnson CS, Trump DL. Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel. Clin Pharmacol Ther 72: 648-659, 2002.
39. Muindi JR, Yu WD, Ma Y, Engler KL, Kong RX, Trump DL, Johnson CS. CYP24A1 inhibition enhances the antitumor activity of calcitriol. Endocrinology 151: 4301-4312, 2010.
40. Nutchey BK, Kaplan JS, Dwivedi PP, Omdahl JL, Ferrante A, May BK, Hii CS. Molecular action of 1,25-dihydroxyvitamin D3 and phorbol ester on the activation of the rat cytochrome P450C24 (CYP24) promoter: role of MAP kinase activities and identification of an important transcription factor binding site. Biochem J 389: 753-762, 2005.
41. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI, Willnow TE. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96: 507-515, 1999.
42. Prudencio J, Akutsu N, Benlimame N, Wang T, Bastien Y, Lin R, Black MJ, Alaoui-Jamali MA, White JH. Action of low calcemic 1α,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma. J Natl Cancer Inst 93: 745-753, 2001.
43. Revelli A, Massobrio M, Tesarik J. Nongenomic effects of 1α,25-dihydroxyvitamin D3. Trends Endocrinol Metab 9: 419-427, 1998.
44. Saeki M, Kurose K, Tohkin M, Hasegawa R. Identification of the functional vitamin D response elements in the human MDR1 gene. Biochem Pharmacol 76: 531-542, 2008.
45. Shinki T, Jin CH, Nishimura A, Nagai Y, Ohyama Y, Noshiro M, Okuda K, Suda T. Parathyroid hormone inhibits 25-hydroxyvitamin D3-24-hydroxylase mRNA expression stimulated by 1α,25-dihydroxyvitamin D3 in rat kidney but not in intestine. J Biol Chem 267: 13757-13762, 1992.
46. Suzuki Y, Landowski CP, Hediger MA. Mechanisms and regulation of epithelial Ca2+ absorption in health and disease. Annu Rev Physiol 70: 257-271, 2008.
47. Swami S, Krishnan AV, Wang JY, Jensen K, Peng L, Albertelli MA, Feldman D. Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo. Horm Cancer 2: 190-202, 2011.
48. Takemoto F, Shinki T, Yokoyama K, Inokami T, Hara S, Yamada A, Kurokawa K, Uchida S. Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats. Kidney Int 64: 414-420, 2003.
49. Takeyama K, Kato S. The vitamin D3 1α-hydroxylase gene and its regulation by active vitamin D3. Biosci Biotechnol Biochem 75: 208-213, 2011.
50. Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E. Transcriptional control of intestinal cytochrome P-4503A by 1α,25-dihydroxyvitamin D3. Mol Pharmacol 60: 1399-1406, 2001.
51. Vieth R, Kooh SW, Balfe JW, Rawlins M, Tinmouth WW. Tracer kinetics and actions of oral and intraperitoneal 1,25-dihydroxyvitamin D3 administration in rats. Kidney Int 38: 857-861, 1990.
52. Wagner D, Dias AG, Schnabl K, Van der Kwast T, Vieth R. Determination of 1,25-dihydroxyvitamin D concentrations in human colon tissues and matched serum samples. Anticancer Res 32: 259-263, 2012.
53. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503-511, 2008.
54. Xue Y, Fleet JC. Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice. Gastroenterology 136: 1317-1327, e1311-e1312, 2009.
55. Yu WD, McElwain MC, Modzelewski RA, Russell DM, Smith DC, Trump DL, Johnson CS. Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone. J Natl Cancer Inst 90: 134-141, 1998.
56. Zierold C, Mings JA, DeLuca HF. Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability. Proc Natl Acad Sci USA 98: 13572-13576, 2001.
57. Zierold C, Mings JA, DeLuca HF. Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone. J Cell Biochem 88: 234-237, 2003.